Health Populi

JUNE 30, 2023

The chart on the median price of newly marketed drugs between 2008 and 2002 shows the cost in 2022 reaching $222,000. PwC calls out this transformation which the COVID-19 pandemic accelerated, when the report notes ambulatory care settings recovered the fastest compared with other delivery sites in the healthcare system.

Prescription Drug Pricing 81

Prescription Drug Pricing COVID-19 ACA Hospitals 81

HIPAA Journal

DECEMBER 14, 2022

The CARES Act was passed by Congress on March 27, 2020, to ensure that every American has access to the care they need during the COVID-19 pandemic and to address the economic fallout from the 2019 Novel Coronavirus and COVID-19. HIPAA Changes in 2020/2021 Due to the COVID-19 Pandemic Remain in Effect.

HIPAA 126

HIPAA COVID-19 COVID-19 Vaccine Compliance 126

HIT Consultant

JANUARY 20, 2022

4 As the most accessible healthcare providers, especially in medically underserved and rural areas, pharmacists most recently played a crucial role in helping the nation combat COVID-19 through administering vaccines, testing, and therapeutics. Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic.”

COVID-19 95

COVID-19 Licensing Doctors 95

SQA

FEBRUARY 22, 2021

NMPA Adjusts Classification Catalog and Down-Classifies Some Medical Devices, 19 January 2021. China’s UDI pilot program wrapped up at the close of 2020; it was previously slated to end in October, but the NMPA extended this trial period due to the impact of the COVID-19 pandemic. China Guidances and Regulations.

COVID-19 52

COVID-19 Compliance Licensing Governance 52

SQA

SEPTEMBER 2, 2022

ANVISA published the RDC 702/2022, which repeals some requirements that were instituted to speed market approval of devices needed to treat patients during the height of the COVID-19 pandemic. The Regulations were first issued with immediate effect in 2002 and were later revised in 2016. 27 May 2022.

FDA 91

FDA COVID-19 Nursing Homes Compliance 91

SQA

AUGUST 2, 2021

COVID-19 Response: Freely Available ISO Standards, 18 June 2021. A number of ISO standards have been made available to support global efforts to address the COVID-19 crisis. ISO 10651-4:2002, Lung ventilators – Part 4: Particular requirements for operator-powered resuscitators.

FDA 83

FDA COVID-19 Pharmaceutical Industry Hospitals 83

SQA

FEBRUARY 26, 2024

These are requirements of the Therapeutic Goods (Medical Devices) Regulations 2002. This guidance replaces the industry guidelines entitled Policy for Testing Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, Including During the Public Health Emergency (COVID-19), which was published in January 2021.

FDA 52

FDA Compliance COVID-19 Public Health 52

SQA

DECEMBER 16, 2022

19 Medical Rehabilitation Equipment. This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells. CMDE Announcement No. 04 Orthopedic Surgical Instruments. 07 Medical Diagnostic and Monitoring Equipment. 08 Respiration, Anesthesia and First Aid Devices.

FDA 40

FDA Compliance COVID-19 Licensing 40

Health Populi

JANUARY 28, 2021

I’ve explored the mine of insights the GWI team has unearthed for the new year, and will focus on one that has fast-grown as the converging forces of the COVID-19 pandemic, economic recession and household financial downturn, and rising anxiety for social and civil justice have, together, wreaked havoc on our mental and behavioral health. .”

COVID-19 81

COVID-19 Doctors Public Health Nurses 81

Drug & Device Law

AUGUST 28, 2023

Just think about how antivax nuts could attempt to attack COVID-19 (or any other) vaccine if the “substantial risk” of “future injury,” Hippo III , 2023 WL 5266026, at *6, necessary for standing to file suit amounts to only a ”fairly likely” possibility that “one of them” might suffer one of four purported “injuries.” 435, 436 (2002).

FDA 52

FDA Doctors Malpractice COVID-19 52

Drug & Device Law

SEPTEMBER 11, 2023

Just think about how routinely antivax nuts could attempt to attack COVID-19 (or any other) vaccine if the “substantial risk” of “future injury,” Hippo III , 2023 WL 5266026, at *6, necessary for standing to file suit amounts to only a ”fairly likely” possibility that “one of them” might suffer one of four purported “injuries.”

FDA 59

FDA Doctors Malpractice COVID-19 59

Drug & Device Law

JANUARY 4, 2024

So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic. 2002); Tracker Marine, L.P. 3d 675, 698 (Tex.

COVID-19 Vaccine 59

COVID-19 Vaccine COVID-19 FDA Public Health 59